Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries

Safety of third trimester immunization with a respiratory syncytial virus F protein vaccine and protection of infants over the first 180 days of life against all-cause lower respiratory tract infection

(2019) G.K. Swamy et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

RSV prevention in infancy and asthma in later life – Authors' reply

(2018) Nienke M Scheltema et al.   Lancet Respiratory Medicine

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

(2017) Ting Shi et al.   LANCET

Maternal Immunization

(2017) Saad B. Omer   NEW ENGLAND JOURNAL OF MEDICINE

Estimating the full public health value of vaccination

(2017) Bradford D. Gessner et al.   VACCINE

Potential impact of a maternal vaccine for RSV: A mathematical modelling study

(2017) Alexandra B. Hogan et al.   VACCINE

Cost–effectiveness thresholds: pros and cons

(2016) Melanie Y Bertram et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Stillbirths: rates, risk factors, and acceleration towards 2030

(2016) Joy E Lawn et al.   LANCET

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

(2016) Kayvon Modjarrad et al.   VACCINE

Cost of management of severe pneumonia in young children: systematic analysis

(2016) Shanshan Zhang et al.   Journal of Global Health

Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings

(2015) Piero Poletti et al.   BMC Medicine

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

(2015) Timothy M. Kinyanjui et al.   PLoS One

Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding

(2014) P. K. MUNYWOKI et al.   EPIDEMIOLOGY AND INFECTION

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

(2014)   PEDIATRICS

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

(2012) Joshua A Salomon et al.   LANCET

Incidence of Respiratory Virus-Associated Pneumonia in Urban Poor Young Children of Dhaka, Bangladesh, 2009–2011

(2012) Nusrat Homaira et al.   PLoS One

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

(2008) Sue J. Goldie et al.   VACCINE

Respiratory Syncytial Virus Infection and Disease in Infants and Young Children Observed from Birth in Kilifi District, Kenya

(2007) D. J. Nokes et al.   CLINICAL INFECTIOUS DISEASES